Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M55,388Revenue $M20,405Net Margin (%)21.7Altman Z-Score3.3
Enterprise Value $M57,712EPS $2.9Operating Margin %14.1Piotroski F-Score7
P/E(ttm)12.4Beneish M-Score-2.6Pre-tax Margin (%)15.6Higher ROA y-yY
Price/Book2.610-y EBITDA Growth Rate %-3.0Quick Ratio1.5Cash flow > EarningsN
Price/Sales2.75-y EBITDA Growth Rate %-19.5Current Ratio1.8Lower Leverage y-yN
Price/Free Cash Flow25.2y-y EBITDA Growth Rate %22.1ROA % (ttm)12.5Higher Current Ratio y-yY
Dividend Yield %2.6PEG--ROE % (ttm)24.0Less Shares Outstanding y-yY
Payout Ratio %56.0Shares Outstanding M1,492ROIC % (ttm)12.2Gross Margin Increase y-yY

Gurus Latest Trades with ABT

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ABTRobert Olstein 2015-12-31 Add0.15%$39.89 - $46.05
($44.24)
$ 37.13-16%Add 14.20%201,000
ABTRichard Pzena 2015-12-31 Reduce-0.08%$39.89 - $46.05
($44.24)
$ 37.13-16%Reduce -6.31%4,861,129
ABTVanguard Health Care Fund 2015-12-31 Reduce-0.08%$39.89 - $46.05
($44.24)
$ 37.13-16%Reduce -13.14%6,027,260
ABTFirst Eagle Investment 2015-12-31 Reduce-0.02%$39.89 - $46.05
($44.24)
$ 37.13-16%Reduce -2.26%6,671,344
ABTKen Fisher 2015-12-31 Add$39.89 - $46.05
($44.21)
$ 37.13-16%Add 13.32%17,286
ABTRichard Pzena 2015-09-30 Reduce-0.32%$39.06 - $51.2
($47.14)
$ 37.13-21%Reduce -18.17%5,188,346
ABTJoel Greenblatt 2015-09-30 Add0.16%$39.06 - $51.2
($47.14)
$ 37.13-21%Add 39.49%1,455,289
ABTGeorge Soros 2015-09-30 Add0.09%$39.06 - $51.2
($47.14)
$ 37.13-21%Add 21.47%731,481
ABTRobert Olstein 2015-09-30 Add0.09%$39.06 - $51.2
($47.14)
$ 37.13-21%Add 10.69%176,000
ABTFirst Eagle Investment 2015-09-30 Add0.09%$39.06 - $51.2
($47.14)
$ 37.13-21%Add 15.36%6,825,289
ABTVanguard Health Care Fund 2015-09-30 Reduce-0.06%$39.06 - $51.2
($47.14)
$ 37.13-21%Reduce -8.60%6,938,700
ABTMario Gabelli 2015-09-30 Reduce-0.01%$39.06 - $51.2
($47.14)
$ 37.13-21%Reduce -71.12%17,625
ABTKen Fisher 2015-09-30 Add$39.06 - $51.2
($47.14)
$ 37.13-21%Add 1.73%15,254
ABTDodge & Cox 2015-09-30 Reduce$39.06 - $51.2
($47.14)
$ 37.13-21%Reduce -3.20%30,268
ABTJoel Greenblatt 2015-06-30 Add0.41%$45.89 - $50.03
($47.99)
$ 37.13-23%Add 2409.54%1,043,293
ABTRobert Olstein 2015-06-30 Reduce-0.1%$45.89 - $50.03
($47.99)
$ 37.13-23%Reduce -11.17%159,000
ABTFirst Eagle Investment 2015-06-30 Add0.09%$45.89 - $50.03
($47.99)
$ 37.13-23%Add 15.05%5,916,570
ABTRichard Pzena 2015-06-30 Reduce-0.01%$45.89 - $50.03
($47.99)
$ 37.13-23%Reduce -0.53%6,340,115
ABTMario Gabelli 2015-06-30 Reduce$45.89 - $50.03
($47.99)
$ 37.13-23%Reduce -6.52%61,032
ABTKen Fisher 2015-06-30 Add$45.89 - $50.03
($47.99)
$ 37.13-23%Add 14.50%14,994
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ABT is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ABT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
WHITE MILES DChairman and CEO 2015-12-16Sell438,000$46-19.28view
Salvadori Daniel Gesua SiveSenior Vice President 2015-09-28Sell815$39.65-6.36view
Fussell Stephen RExecutive Vice President 2015-08-18Sell13,096$50.46-26.42view
Blaser Brian JExecutive Vice President 2015-07-28Sell11,300$50.96-27.14view
Pavee Jean-YvesSenior Vice President 2015-06-03Sell10,500$49-24.22view
Mason Heather LExecutive Vice President 2015-04-27Sell13,500$47.45-21.75view
BIRD ROGERSenior Vice President 2015-04-27Sell28,548$47.57-21.95view
Contreras JaimeSenior Vice President 2015-03-31Sell228$46.43-20.03view
White J. ScottSenior Vice President 2015-03-26Sell12,483$46.68-20.46view
Warmuth Michael JExecutive Vice President 2015-03-10Sell13,500$46.41-20view

Quarterly/Annual Reports about ABT:

    News about ABT:

    Articles On GuruFocus.com
    Valeant's Share Price Continues to Decline Feb 05 2016 
    Abbott a Dividend Aristocrat Stock Propelled by Emerging Markets Dec 11 2015 
    Baxalta Vs. AbbVie: Biopharma Spin-Off Battle Aug 20 2015 
    Profit from Emerging Market Health Care Growth With Abbott Laboratories Jul 25 2015 
    Becton and Dickinson: A Long-Term Bet Jul 08 2015 
    Mason Hawkins Comments on Abbott Laboratories May 28 2015 
    Endo International Posts Upbeat Q1 Results May 13 2015 
    How Much Money Will You Need To Retire? Mar 31 2015 
    Top Stock Picks Among Companies That Recently Increased Dividends Mar 09 2015 
    Endo International Shares Upbeat After Positive Q4 Earnings Report Mar 03 2015 

    More From Other Websites
    Alere–Abbott Labs Is a Large, Strategic Deal for Arbitrageurs Feb 13 2016
    Can Zoetis (ZTS) Keep the Earnings Streak Alive in Q4? Feb 12 2016
    Mylan to buy Sweden's Meda AB for $7.2 billion Feb 10 2016
    Mylan to buy Sweden's Meda AB for $7.2 billion Feb 10 2016
    How Did Boston Scientific’s Stock Move after Its 4Q15 Earnings Release? Feb 10 2016
    New Strong Sell Stocks for February 10th Feb 10 2016
    The Alere-Abbott Labs Merger: Understanding the Alere Side Feb 09 2016
    Abbott Introduces New 'Foodie' Inspired Snack Brand: Curate Feb 09 2016
    Abbott Brings ‘Salted Decadence’ Bars to Crowded Snack Aisle Feb 09 2016
    Extra Space Storage, Abbott Laboratories, First Data, ServiceMaster Global Holdings and ABM... Feb 08 2016
    Law Offices of Marc S. Henzel Announces Investigation of Companies for Violations of the Federal... Feb 08 2016
    Looking Into the Price Movements - Consensus Reports on Astrazeneca, Abbott Laboratories, Keurig... Feb 08 2016
    Bear of the Day: Abbott Labs (ABT) Feb 08 2016
    SHAREHOLDER ALERT: The Law Offices of Vincent Wong Launches an Investigation of the Board of... Feb 04 2016
    ​Alere executives stand to reap $24M in payouts with Abbott buyout Feb 04 2016
    Rationale for the Alere–Abbott Laboratories Merger Feb 04 2016
    Abbott Labs Beefs Up Its Diagnostics Portfolio with Alere Feb 04 2016
    Abbott Laboratories Posts Weak Guidance for 2016 Feb 04 2016
    Abbott Established Pharmaceuticals: Impact of Currency Headwinds Feb 04 2016
    What Makes Abbott Laboratories (ABT) a Strong Sell? Feb 04 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK